MBRX – moleculin biotech, inc. (US:NASDAQ)

News

Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
Moleculin Launches CEO Corner Platform to Share Strategic Insights
Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com